Best Practice Guidance on Joint Working between the HSC and the Pharmaceutical Industry and other relevant organisations (PDF 260KB)

HSS (GEN) 1) 1/95 update. It is intended to replace the guidance previously provided by former HSSBs and Trusts to assist employers and staff in maintaining strict ethical standards in the conduct of HSC business, in this instance, with the pharmaceutical industry

Notification of a disability or long term health condition (Guidance notes and form) (PDF 133KB)

Provides guidance and advice on notifying a disability/long-term health condition to PMB and on requesting a reasonable adjustment, if you have previously declared a disability/long-term health condition.

Domestic Violence and Abuse - Guidance for Employers (PDF 219 KB)

Developing a workplace Policy on Domestic Violence and Abuse - Guidance for Employers

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland (PDF 270 KB)

Provides clear information on the practical implementation of supplementary prescribing.

Guidance on Analysis (PDF 87 KB)

HPSS Guidance on Analysist of Risk/Risk Rating Matrix

Project Fundaing Application and Guidance Notes (PDF 310 KB)

2005 - 2006

Leaving and After Care Guidance and Regulations

The eighth volume in the series of Regulations and Guidance produced in the context of the Children (Northern Ireland) Order 1995.

Guidance on Drug and Substance Misuse in Mental Health Care Settings (PDF 954 KB)

Guidance on Drug and Substance Misuse in Mental Health Care Settings

Guidance on Discharge from Hospital and the Continuing Care in the Community of People with a Mental Disorder who could Represent a Risk of Serious Physical Harm to Themselves or Others (PDF 985 KB)

Guidance on Discharge from Hospital and the Continuing Care in the Community of People with a Mental Disorder who could Represent a Risk of Serious Physical Harm to Themselves or Others

Regional Advisory Committee on Cancer - Guidance for the Management of Haematological Cancer (September 2004) (PDF 163 KB)

Haematological cancers in adults include a range of diseases including leukaemias, lymphomas and myeloma, all of which differ in diagnosis and management. Collectively they account for about 1 in 14 cancers. This guidance provides a profile of the major haematological malignancies with brief reference to relevant epidemiological factors and management implications. It emphasises the collaborative and specialised nature of the clinical haematology service currently being delivered in the Cancer Centre and Cancer Units on a hub and spoke basis. The guidance sets out recommendations aimed at strengthening the current clinical service, which should continue to operate as a network, facilitating rapid referrals and the use of shared protocols. Specifically, it recommends that patients should be managed by a multi-disciplinary approach and that the provision of diagnostic facilities including radiological and cytogenetic analysis must be sufficient to provide high quality and timely information. åÊ

Draft Leaving and After Care Regulations and Guidance for Consultation (PDF 350 KB)

Children (Leaving Care) Act (NI) 2002